
SGHT Earnings
Sight Sciences Inc
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Sight Sciences Inc(SGHT) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Sight Sciences Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
FY2025Q2 | 2025-08-07 | After Hours | -0.25 | -0.23 | +8.00 | 18.18M | 19.56M | +7.60 | +19.44 | - |
FY2025Q1 | 2025-05-08 | After Hours | -0.29 | -0.28 | +3.45 | 16.51M | 17.51M | +6.03 | +1.65 | +8.25 |
FY2024Q4 | 2025-03-05 | After Hours | -0.20 | -0.23 | -15.00 | 19.00M | 19.07M | +0.39 | +2.89 | +11.16 |
FY2024Q2 | 2024-08-01 | - | -0.31 | -0.25 | +19.35 | 21.35M | 21.37M | +0.10 | -4.63 | -29.18 |
FY2024Q1 | 2024-05-02 | - | -0.29 | -0.33 | -13.79 | 18.39M | 19.27M | +4.78 | +0.36 | -0.72 |
FY2023Q4 | 2024-03-07 | - | -0.35 | -0.22 | +37.14 | 19.40M | 18.75M | -3.33 | +0.66 | -4.38 |
FY2023Q3 | 2023-11-07 | - | -0.31 | -0.27 | +12.90 | 20.89M | 20.01M | -4.22 | +22.09 | +4.94 |
FY2023Q2 | 2023-08-03 | - | -0.35 | -0.30 | +14.29 | 22.39M | 23.47M | +4.81 | +3.21 | +1.41 |
- | 2023-05-04 | - | -0.41 | -0.35 | +14.63 | - | - | - | +6.27 | -0.40 |
- | 2023-03-13 | - | -0.42 | -0.35 | +16.67 | - | - | - | +1.51 | -2.27 |
SGHT Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Sight Sciences Inc reported performance for FY2025Q2, announced on 2025-08-07. The company achieved an EPS of -0.23, compared to analyst estimates of -0.25 by 8.00% . Revenue for the quarter reached 19.56M compared to expectations of 18.18M by 7.60% .
The stock price reacted with a 19.44% one-day change and a % five-day change following the earnings release. These movements reflect market reaction in Sight Sciences Inc growth trajectory and strategic initiatives.
SGHT Earnings Forecast
Looking ahead, Sight Sciences Inc(SGHT) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q3 project quarter revenue of 17.74M and an EPS of -0.26.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming Q3 2025, revenue estimates have been adjusted Revise Upward by 1.14% . These revisions correlate with a 28.35% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Sight Sciences Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between SGHT's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Revenue Estimates for Q3 2025
Revise Upward

+1.14%
In Past 3 Month
Stock Price
Go Up

+28.35%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:73.40M
--
EPS Estimate-Annual FY 2025:-1.09
—
Stock Price4.12
SGHT Revenue and EPS Performance: A Historical Perspective
Sight Sciences Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-08-07,After Hours):
EPS: -0.23 (Actual) vs.-0.25 (Estimate) (8.00%)
Revenue: 19.56M (Actual) vs. 18.18M (Estimate) (7.60%)
Price Reaction: 19.44%(1-Day), %(5-Day)
FY2025Q1 (2025-05-08,After Hours):
EPS: -0.28 (Actual) vs.-0.29 (Estimate) (3.45%)
Revenue: 17.51M (Actual) vs. 16.51M (Estimate) (6.03%)
Price Reaction: 1.65%(1-Day), 8.25%(5-Day)
FY2024Q4 (2025-03-05,After Hours):
EPS: -0.23 (Actual) vs.-0.20 (Estimate) (-15.00%)
Revenue: 19.07M (Actual) vs. 19.00M (Estimate) (0.39%)
Price Reaction: 2.89%(1-Day), 11.16%(5-Day)
Earnings Reaction
The chart below shows how SGHT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, SGHT sees a +7.94% change in stock price 10 days leading up to the earnings, and a +4.60% change 10 days following the report. On the earnings day itself, the stock moves by +2.99%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed 19.44% on the day following the earnings release and then changed by 16.06% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Sight Sciences Inc (SGHT) Q2 2025 Earnings Call Summary
Neutral
2025-08-08
The earnings call reveals mixed signals: the company reports declining dry eye revenue and gross margins, alongside a net loss. However, they also demonstrate strong performance in the Surgical Glaucoma segment, reduced operating expenses, and positive cash flow. The Q&A highlights confidence in reimbursement for TearCare and market share gains in MIGS, but uncertainties in reimbursement timing and competitive dynamics persist. These factors, coupled with stable guidance, suggest a neutral stock price movement over the next two weeks.
Sight Sciences Inc (SGHT) Q1 2025 Earnings Call Summary
Negative
2025-05-10
The earnings call reveals a challenging environment with decreased revenues, competitive pressures, and regulatory issues. The lack of reimbursement coverage for TearCare and declining MIGS utilization are concerning. Despite a slight decrease in net loss, the company faces tariff impacts and lacks a share repurchase program. The Q&A section highlights management's evasive responses on key issues, adding to uncertainty. Overall, the negative factors outweigh any positives, leading to a negative sentiment rating.
Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Summary
Negative
2025-03-06
The earnings call reveals several challenges: competitive pressures, reimbursement issues, and financial losses. Despite some positive elements like revenue growth in surgical glaucoma and improved gross margins, the lack of shareholder return plans and specific guidance, along with the net loss, overshadow these positives. The Q&A section highlighted management's vague responses, adding uncertainty. Overall, the company's position is weakened by these factors, suggesting a negative stock price reaction.
Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Summary
Negative
2025-03-05
The earnings call reveals several concerning factors: a decline in dry eye revenue, increased operating expenses, and a net loss. Additionally, regulatory issues and tariffs pose risks to future revenue and margins. The lack of a shareholder return plan and unclear responses from management further dampen sentiment. Despite some positive aspects, such as increased surgical glaucoma revenue and improved cash flow, the overall outlook is negative due to significant uncertainties and challenges.
Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Summary
Neutral
2025-03-05
The earnings call presents mixed signals: a slight revenue increase and improved gross margins, but with a net loss and cautious financial outlook. The Q&A reveals uncertainties in reimbursement and market growth, particularly in the MIGS and Tier Care segments. While the company has a solid cash position and plans for breakeven, the lack of specific guidance and potential market restrictions dampen optimism. Overall, the sentiment is neutral due to balanced positive and negative factors.
Sight Sciences, Inc. (SGHT) Q3 2024 Earnings Call Summary
Negative
2024-11-09
The earnings call reveals mixed financial performance, with revenue growth below expectations and declining gross margins. The lack of a shareholder return plan and uncertainty in economic factors further dampen sentiment. While there is optimism for future growth, management's reluctance to provide specific guidance and the challenges in the dry eye and glaucoma segments contribute to a negative outlook. The Q&A section highlights concerns about procedural impacts and cash flow, reinforcing the negative sentiment. Overall, the stock is likely to experience a negative reaction, falling between -2% to -8%.
Sight Sciences, Inc. (SGHT) Q2 2024 Earnings Call Summary
Neutral
2024-08-03
The earnings call presents a mixed sentiment. Financial performance shows sequential growth but a decline YoY, with weak guidance. The Q&A section highlights concerns over cash flow breakeven and uncertainties in reimbursement processes. Despite improvements in cash usage and operating expenses, the lack of clear guidance and weak revenue outlooks temper positive aspects like cash reserves and cost management. The planned price increase for TearCare and optimistic future growth expectations are counterbalanced by the absence of immediate catalysts. Overall, the sentiment is neutral, suggesting limited stock price movement.
People Also Watch

FRGE
Forge Global Holdings Inc
22.380
USD
+2.47%

VERU
Veru Inc
3.590
USD
-3.68%

VTYX
Ventyx Biosciences Inc
2.640
USD
-6.05%

MPAA
Motorcar Parts of America Inc
13.810
USD
+22.43%

OPRT
Oportun Financial Corp
5.860
USD
-0.51%

TDTH
Trident Digital Tech Holdings Ltd
0.899
USD
-17.52%

ALTO
Alto Ingredients Inc
1.010
USD
-4.72%

WHG
Westwood Holdings Group Inc
17.400
USD
+6.23%

INMB
INmune Bio Inc
2.400
USD
-6.25%

HOFT
Hooker Furnishings Corp
9.300
USD
0.00%
FAQ

What were the key highlights of SGHT’s latest earnings report for FY2025Q2?
SGHT reported its FY2025Q2 earnings on 2025-08-07, showcasing a revenue of 19.56M against an estimate of 18.18M, resulting in a 7.6% surprise. The EPS was -0.23, surpassing the expected -0.25 by 8% . The stock experienced a 19.44% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

How did SGHT’s stock price react after the FY2025Q2 earnings release?

What are the revenue and EPS estimates for SGHT for 2025/Q3?

How does SGHT’s stock price correlate with earnings forecast revisions?

What should investors expect from SGHT’s next earnings report?
